SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIbstock Regulatory News (IBST)

Share Price Information for Ibstock (IBST)

Share Price is delayed by 15 minutes
Get Live Data
95.00    3.15 (3.43%)
Bid:
95.05
Ask:
95.60
Spread: 0.55 (0.579%)
Market Cap: £375.27m
IBST Live PriceLast checked at - London Stock Exchange

Intraday Ibstock Share Chart

Trading Update

3 Jun 2020 07:00

RNS Number : 7456O
Ibstock PLC
03 June 2020
 

Trading Update

Ibstock plc ('Ibstock' or the 'Group'), a leading manufacturer of clay bricks and concrete products in the United Kingdom, today issues a trading update for the five months ended 31 May 2020.

Trading performance

Sales volumes during the first 10 weeks of the year were, as anticipated, modestly below the comparative period as we entered 2020 against the backdrop of more subdued market conditions. The Group saw a sharp decline in sales volumes from late March as the Government measures to control the Covid-19 pandemic began to take effect and our construction and housebuilding customers closed sites. During April, volumes in our Clay division fell by around 90% year on year, whilst exposure to infrastructure and RMI markets meant that volumes in our Concrete division remained relatively more resilient during that period.

As the construction and housebuilding sectors have begun to return to work over recent weeks, trading conditions have started to improve. We have seen a modest recovery in clay brick sales although volumes currently remain around 70% below the comparative period. Concrete volumes are now at around 50% of those from the same period in 2019.

Overall, Group revenues for the three months to 31 March 2020 were down by approximately 10% compared to the comparative period, with a decline of around 75% in the two months to 31 May 2020.

Operations

As announced on 15 May 2020, the Group has developed new working practices and protocols which reflect the latest guidance from the Government and public health authorities. This has allowed the recommencement of production at approximately one third of our manufacturing sites in response to customer demand. The Group will keep demand levels under close review and is able to restart production at further manufacturing sites over the coming months as required.

The Group has taken significant action to address the challenges presented by Covid-19. These measures have included utilising the Government's Coronavirus Job Retention Scheme for a significant portion of colleagues during the shutdown period, reducing discretionary spend wherever possible and implementing a temporary salary reduction for the Board and the executive leadership team.

In addition, in order to ensure that the business remains well-positioned as it emerges from the current crisis, we are conducting a review of all operations. This review is expected to lead to a material reduction in the Group's fixed cost base, through selective site closures, changes in operating patterns and changes to the size and structure of support functions. We have entered into consultations with employees across the Group as part of a series of restructuring proposals, with up to 375 positions, representing around 15 per cent of the Group's total workforce, potentially impacted as a result of these actions.

Whilst the changes anticipated will ensure our business is adapted to the near-term industry demand outlook, we retain the flexibility to scale production back up, as and when demand recovers.

Financial position

In addition to actions taken to reduce costs, the Group is continuing to prioritise liquidity and the preservation of cash to enhance its financial resilience and flexibility in response to Covid-19. In particular, this has included close management of working capital and deferral of non-essential capital expenditure and tax payments as allowed by Government schemes. As a result, net debt at 31 May 2020 was approximately £105 million, primarily reflecting seasonal working capital movements early in the year, and the Group continues to have significant liquidity headroom within its £215 million revolving credit facility ("RCF"), which expires in March 2022.

To maintain financial flexibility, the Group has secured agreement from its lending banks for a number of amendments to covenant tests under the Group's RCF1. The Group is also pleased to announce that it has been confirmed as eligible in principle to access funding under the Covid Corporate Financing Facility ("CCFF"), subject to the Bank of England approving relevant documentation.

Outlook

With the health and safety of our colleagues remaining our top priority, the phased return to production is underway, to support our customers and help the UK construction sector get building again.

Current trading conditions remain difficult but the combination of the cost reductions, restructuring measures and improved liquidity have strengthened the Group's ability to meet current challenges and benefit from the eventual recovery in its core markets.

As a result of current unprecedented levels of uncertainty, it is not possible to provide an accurate assessment of the trading outlook for the current year, and accordingly, guidance remains withdrawn.

1 Existing covenants under the Group's RCF facility require: leverage of no more than 3 times net debt to EBITDA; and interest cover of no less than 4 times, tested bi-annually at each reporting date.

The leverage test as at December 2020 will be replaced by a liquidity test requiring the Group to have Minimum Liquidity of £60 million. Liquidity defined as: (Cash and Equivalents) + (Available Existing RCF Commitments) - (Any Outstanding Drawings under the CCFF).

The interest cover test as at December 2020 will be amended to no less than 1.25 times.

The leverage test as at 30 June 2021 will be amended to no more than 3.75 times net debt to EBITDA.

Enquiries to:

Ibstock plc

Joe Hudson, CEO

Chris McLeish, CFO

Robert Coates, Investor Relations Director

07880 486329

Citigate Dewe Rogerson

020 7638 9571

Kevin Smith

Nick Hayns

 

About Ibstock Plc

Ibstock plc is a leading manufacturer of clay bricks and a diversified range of clay and concrete products, from its operations in the United Kingdom. Its principal products are clay bricks, brick components, concrete roof tiles, concrete substitutes for stone masonry, concrete fencing and pre‐stressed concrete products.

 

The Group's two divisions are:

 

Ibstock Clay: The leading manufacturer by volume of clay bricks sold in the United Kingdom. With 19 manufacturing sites Ibstock Brick has the largest brick production capacity in the United Kingdom. It operates a network of 23 active quarries located close to its manufacturing plants. Ibstock Brick has recently commissioned a new soft mud brick manufacturing plant in Leicestershire that added approximately 100 million bricks to its brick production capacity per annum. Ibstock Kevington provides masonry and pre-fabricated component building solutions, operating from 5 sites across the UK.

 

Ibstock Concrete: A leading manufacturer of concrete roofing, walling, flooring and fencing products, along with lintels and general concrete building products, with 16 manufacturing plants in the United Kingdom.

 

Forward-looking statements

This announcement contains "forward-looking statements". These forward-looking statements include all matters that are not historical facts and include statements regarding the intentions, beliefs or current expectations of the directors. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances that are difficult to predict and outside of the Group's ability to control. Forward-looking statements are not guarantees of future performance and the actual results of the Group's operations. Forward-looking statements speak only as of the date of such statements and, except as required by applicable law, the Group undertakes no obligation to update or revise publicly any forward-looking statements.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKLLFBBQLBBBF
Date   Source Headline
11th Jun 20257:00 amRNSSecond Quarter Trading Update
9th Jun 202511:00 amRNSHolding(s) in Company
5th Jun 20259:53 amRNSHolding(s) in Company
4th Jun 20253:41 pmRNSHolding(s) in Company
2nd Jun 20254:11 pmRNSTotal Voting Rights
27th May 20253:16 pmRNSDirector/PDMR Shareholding
15th May 20252:09 pmRNSResult of AGM
13th May 20252:02 pmRNSHolding(s) in Company
1st May 20253:30 pmRNSDirector/PDMR Shareholding
1st May 20253:00 pmRNSHolding(s) in Company
1st May 202510:25 amRNSTotal Voting Rights
30th Apr 20257:00 amRNSDirectorate Change
23rd Apr 20257:00 amRNSFirst Quarter Trading Update
11th Apr 20254:05 pmRNSNotice of AGM
4th Apr 20254:00 pmRNSHolding(s) in Company
1st Apr 20258:47 amRNSTotal Voting Rights
25th Mar 20257:00 amRNSAppointment of Chair
21st Mar 20251:33 pmRNSDirector/PDMR Shareholding
19th Mar 20254:24 pmRNSHolding(s) in Company
5th Mar 20257:00 amRNSResults for the year ended 31 December 2024
27th Feb 20254:15 pmRNSHolding(s) in Company
16th Jan 20257:00 amRNSTrading Update for the year ended 31 December 2024
2nd Jan 20259:30 amRNSBlock listing Six Monthly Return
2nd Jan 20259:00 amRNSTotal Voting Rights
23rd Dec 20242:44 pmRNSStandard form for notification of major holdings
2nd Dec 20248:32 amRNSTotal Voting Rights
15th Nov 20242:00 pmRNSHolding(s) in Company
18th Oct 202410:30 amRNSHolding(s) in Company
17th Oct 20247:00 amRNSThird Quarter Trading Update
9th Oct 20243:00 pmRNSHolding(s) in Company
7th Oct 20249:30 amRNSHolding(s) in Company
1st Oct 202411:56 amRNSTotal Voting Rights
5th Sep 20244:17 pmRNSHolding(s) in Company
2nd Sep 20248:51 amRNSTotal Voting Rights
16th Aug 202412:00 pmRNSHolding(s) in Company
13th Aug 20243:30 pmRNSHolding(s) in Company
12th Aug 202412:06 pmRNSDirector/PDMR Shareholding
7th Aug 20247:00 amRNSInterim Results
1st Aug 20243:17 pmRNSTotal Voting Rights
29th Jul 20243:00 pmRNSHolding(s) in Company
23rd Jul 20243:00 pmRNSHolding(s) in Company
22nd Jul 20244:20 pmRNSHolding(s) in Company
11th Jul 20244:00 pmRNSHolding(s) in Company
9th Jul 20242:00 pmRNSHolding(s) in Company
1st Jul 20249:00 amRNSBlock Listing Six Monthly Return
1st Jul 20249:00 amRNSTotal Voting Rights
20th Jun 20241:59 pmRNSReport on Payments to Govts
17th Jun 20243:55 pmRNSHolding(s) in Company
14th Jun 20243:45 pmRNSHolding(s) in Company
12th Jun 20243:48 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.